FDA Approves Lyvispah (baclofen) Oral Granules for the Treatment of Spasticity

ROSWELL, Ga. and DUBLIN and HAMILTON, Bermuda, Dec. 7, 2021 /PRNewswire/ -- Saol Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved Saol ' s Lyvispah (baclofen) oral granules. Lyvispah (lye-vis ' -pah) is...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news